CLINICAL_TRIALS
trial_result
· 2019-02-06
Clinical Trial Update: Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils [Phase 3]
Summary
Phase 3 trial update for reslizumab in uncontrolled asthma with high eosinophils; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-02-06